 |
 |

Utility of Emergency, Telephone-Based National Surveillance for Hantavirus Pulmonary Syndrome
Jordan W. Tappero, MD, MPH;
Ali S. Khan, MD;
Robert W. Pinner, MD;
Jay D. Wenger, MD;
Judith M. Graber, MS;
Lori R. Armstrong, PhD;
Robert C. Holman, MS;
Thomas G. Ksiazek, DVM, PhD;
Rima F. Khabbaz, MD;
Hantavirus Task Force;
Sally P. Bauer, MS;
Jay C. Butler, MD;
Matthew J. Clarke, MA;
Patrick J. McConnon;
Dawn Morgado, MPH;
Stuart T. Nichol, PhD;
C. J. Peters, MD;
Anne K. Pflieger, MPH;
Pierre E. Rollin, MD;
Mark J. Sotir, MPH;
Tara W. Strine;
Susan J. Sweeney, MPH;
Sherif R. Zaki, MD
JAMA. 1996;275(5):398-400.
Abstract
 |  |
On May 27,1993, in response to the outbreak investigation of newly recognized Hantavirus pulmonary syndrome (HPS) in the Four Corners states (New Mexico, Arizona, Utah, and Colorado), the Centers for Disease Control and Prevention established a national surveillance case definition for severe, unexplained respiratory disease to determine the extent of HPS throughout the United States. A toll-free telephone hotline number was instituted to provide updated information about unexplained respiratory illness and to serve as a passive mechanism for reporting suspected cases. Clinical information was obtained from callers reporting suspected cases, and diagnostic specimens and medical record reviews were requested from health care providers. From June 3 through December 31, 1993, the hotline received 21 443 telephone inquiries; callers identified 280 suspected cases living outside the Four Corners states with at least one specimen available for diagnostic testing. By December 31, 1993, 21 confirmed cases (age range, 14 to 58 years) residing in 11 states outside the Four Corners region had been identified. This passive surveillance system was successful in rapidly identifying the widespread sporadic geographic distribution for HPS cases throughout the United States and could serve as a model for similar emergencies. Expanding and coordinating surveillance systems for the early detection, tracking, and evaluation of emerging infections is a critical component of disease prevention.
(JAMA. 1996;275:398-400)
Author Affiliations
From the Childhood and Respiratory Diseases Branch (Drs Tappero and Wenger) and the Emerging Bacterial and Mycotic Diseases Branch (Dr Pinner), Division of Bacterial and Mycotic Diseases; Special Pathogens Branch (Drs Khan, Armstrong, Ksiazek, Khabbaz, and Ms Graber) and Biometrics Activity (Mr Holman), Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Ga.
Footnotes
This article is one of a series addressing emerging and reemerging global microbial threats.
Reprint requests to Centers for Disease Control and Prevention, National Center for Infectious Diseases, Division of Viral and Rickettsial Diseases, Office of the Director, Mail Stop (A30), 1600 Clifton Rd NE, Atlanta, GA 30333 (Dr Khabbaz).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|